{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:28:16Z","timestamp":1758040096179,"version":"3.44.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL094761"],"award-info":[{"award-number":["HL094761"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.amjcard.2013.10.031","type":"journal-article","created":{"date-parts":[[2013,11,9]],"date-time":"2013-11-09T09:46:19Z","timestamp":1383990379000},"page":"475-479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Usefulness of Pharmacologic Conversion of Atrial Fibrillation During Dofetilide Loading Without the Need for Electrical Cardioversion to Predict Durable Response to Therapy"],"prefix":"10.1016","volume":"113","author":[{"given":"Rohit","family":"Malhotra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth C.","family":"Bilchick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"DiMarco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2013.10.031_bib1","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/01.CIR.102.19.2385","article-title":"Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial\u00a0flutter: the Symptomatic Atrial Fibrillation Investigative Research\u00a0on\u00a0Dofetilide (SAFIRE-D) study","volume":"102","author":"Singh","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2013.10.031_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/14779072.5.1.9","article-title":"Dofetilide: a new class III antiarrhythmic agent","volume":"5","author":"Roukoz","year":"2006","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.amjcard.2013.10.031_bib3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1358\/dot.2000.36.11.601530","article-title":"Dofetilide: a new antiarrhythmic agent approved for conversion and\/or maintenance of atrial fibrillation\/atrial flutter","volume":"36","author":"Lenz","year":"2000","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.amjcard.2013.10.031_bib4","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1053\/euhj.1999.2039","article-title":"Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study","volume":"21","author":"Bianconi","year":"2000","journal-title":"Euro Heart J"},{"key":"10.1016\/j.amjcard.2013.10.031_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10840-008-9290-6","article-title":"Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter","volume":"23","author":"Banchs","year":"2008","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.amjcard.2013.10.031_bib6","unstructured":"USPI Tikosyn PDF Document. Available at: http:\/\/lp.ncdownloader.com\/eb2\/?q=USPI%20TIKOSYN%20PDF. Accessed on January 15, 2013."},{"key":"10.1016\/j.amjcard.2013.10.031_bib7","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCULATIONAHA.106.177031","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2013.10.031_bib8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/01.HYP.0000052830.02773.E4","article-title":"Atrial fibrillation in hypertension","volume":"41","author":"Verdecchia","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2013.10.031_bib9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.pcad.2005.09.001","article-title":"Atrial fibrillation and congestive heart failure: risk factors, mechanisms, and treatment","volume":"48","author":"Heist","year":"2006","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.amjcard.2013.10.031_bib10","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM199909163411201","article-title":"Dofetilide in patients with congestive heart failure and left ventricular dysfunction","volume":"341","author":"Torp-Pedersen","year":"1999","journal-title":"New Engl JMed"},{"key":"10.1016\/j.amjcard.2013.10.031_bib11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.amjmed.2005.01.031","article-title":"Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study","volume":"118","author":"Frost","year":"2005","journal-title":"AmJ Med"},{"key":"10.1016\/j.amjcard.2013.10.031_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjcard.2011.03.004","article-title":"Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation","volume":"108","author":"Huxley","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2013.10.031_bib13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/01.CIR.53.2.273","article-title":"Relation between echocardiographically determined left atrial size and atrial fibrillation","volume":"53","author":"Henry","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2013.10.031_bib14","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.amjcard.2013.10.031_bib15","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/europace\/eun124","article-title":"New risk factors for atrial fibrillation: causes of \u2018not-so-lone atrial fibrillation\u2019","volume":"10","author":"Schoonderwoerd","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2013.10.031_bib16","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1046\/j.1540-8167.2003.90402.x","article-title":"Clinical experience with dofetilide in the treatment of patients with atrial fibrillation","volume":"14","author":"Prystowsky","year":"2003","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.amjcard.2013.10.031_bib17","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1345\/aph.1D465","article-title":"Phase IV trial evaluating the effectiveness and safety of dofetilide","volume":"38","author":"Guanzon","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjcard.2013.10.031_bib18","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM200003303421302","article-title":"Amiodarone to prevent recurrence of atrial fibrillation","volume":"342","author":"Roy","year":"2000","journal-title":"New Engl J Med"},{"key":"10.1016\/j.amjcard.2013.10.031_bib19","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/j.1540-8159.2007.00902.x","article-title":"Acute conversion of persistent atrial fibrillation during dofetilide initiation","volume":"30","author":"Cotiga","year":"2007","journal-title":"Pacing Clin Electrophysiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914913021619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914913021619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:26:02Z","timestamp":1757571962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914913021619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0002914913021619"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2013.10.031","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness of Pharmacologic Conversion of Atrial Fibrillation During Dofetilide Loading Without the Need for Electrical Cardioversion to Predict Durable Response to Therapy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2013.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}